At the 2025 NAPNAP National Conference, Maureen Madden, DNP, CPNP-AC, CCRN, FCCM, FAAN, explained why the yearly conference is important for both providers and pediatric patients. Maureen Madden, DNP, ...

Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, reacts to the recent cancelations of the ACIP and VRBPAC and comments on the potential down stream effects. The ACIP meeting was originally slated for ...

At the 2025 NAPNAP National Conference, Maureen Madden, DNP, CPNP-AC, CCRN, FCCM, FAAN, provides the key takeaways and recommendations for glycemic control guidance, updated in 2024. In this video ...

The study, known as BRAVE-AA-PEDS, was sponsored by Eli Lilly and Company and involved 257 adolescents aged 12 to under 18 years. Baricitinib, an oral Janus kinase (JAK) inhibitor, demonstrated ...

A presentation at the 46th National Association of Pediatric Nurse Practitioners (NAPNAP) conference explored the role of biologics in pediatric care, their applications in various conditions, and ...

Organon has recently announced new results from the phase 3 ADORING 3 open-label, long-term extension study evaluating tapinarof cream, 1% (VTAMA), for the treatment of atopic dermatitis (AD). The ...

A quick look into some of the top sessions occurring at the NAPNAP National Conference, being held from March 10-13, 2025 in Chicago, IL. The National Association of Pediatric Nurse Practitioners ...

Over the past decade, there has been an emergence of commercially available home devices to help monitor an infant’s vital signs during sleep. These devices aim to provide reassurance and peace of ...

Lebrikizumab improves itch, sleep interference, and skin pain in atopic dermatitis patients previously treated with dupilumab, offering a new treatment option. A new Phase-3b study has found that ...

Bobbie Labs has announced the planned launch of Bobbie Organic Whole Milk Formula, which the company bills as the first and only USDA Organic Whole Milk infant formula on the US market. Announced on ...

Jay T. Rubinstein, MD, PhD, highlighted promising CHORD trial data showing that DB-OTO gene therapy has led to hearing improvements in treated participants. New data from the CHORD trial (NCT05788536) ...

Study: Nearly 80% of infants born in 2023-24 RSV season received RSV protection ...